• news.cision.com/
  • CLS/
  • AVANT Concierge Urology in Florida USA has treated its first patients using CLS’s TRANBERG system

AVANT Concierge Urology in Florida USA has treated its first patients using CLS’s TRANBERG system

Report this content

Lund, Sweden – Clinical Laserthermia Systems AB (publ) (“CLS” or “the Company”) announces today that AVANT Concierge Urology, which CLS's US subsidiary entered into a Mobile Service Provider (“MSP”) agreement with at the end of April, has now treated its first patients using CLS’s TRANBERG™ system.

AVANT Concierge Urology, based in Florida, USA, has now safely treated its first low-to-intermediate risk prostate cancer patients using CLS TRANBERG Thermal Therapy System. Under the agreement, CLS provides its FDA 510(k) cleared TRANBERG Thermal Therapy System in a bundled service offering, with consumable accessories, training, and on-site clinical and technical staff support to AVANT physicians and staff during procedures.

 

AVANT Concierge Urology is excited to begin offering its patients this safe, minimally invasive prostate cancer treatment in the convenience of our office as an outpatient procedure,” stated Dr. Sijo Parekattil, Director of AVANT Concierge Urology. “Most treatments are quick and take less than two hours. Patients usually have only minor pain and recover quickly.

 

"I am pleased to see the positive impact of our bundled service offering on the timeline for starting up a new customer. It means that prostate cancer patients more quickly get access to a minimal invasive treatment option without the typical risk profile and the complications that are associated to radiation and open surgery. It is also a confirmation that CLS agreement with bundled services is an easy way for clinics to start offering what prostate cancer patients are asking for. A positive experience we will continue to build on,” says Dan J Mogren, CEO Clinical Laserthermia Systems AB.

 

In the US, over one million prostate biopsies are performed every year leading to a diagnosis of prostate cancer for almost 250,000 men. Focal laser ablation of prostate tumors has demonstrated high levels of precision and accuracy with low risk of side effects, such as erectile dysfunction and urinary incontinence.

 

 

The information was submitted for publication, through the agency of the contact person set out below on 11 May 2023.

 

 

For more information, please contact:

Dan J. Mogren, CEO, Clinical Laserthermia Systems AB (publ)

Phone: +46 (0) 70-590 11 40
E-mail: dan.mogren@clinicallaser.com

 

 

About Avant Concierge Urology

Avant Concierge Urology is Central Florida’s premier urology practice, specializing in the treatment of conditions related to the kidneys, urinary bladder, adrenal glands, urethra, and male reproductive organs. Regardless of whether you’re male or female, you can count on Avant for the personalized care you deserve. In addition to helping to provide optimal health for the organs of the genitourinary tract, Avant offers best-in-class surgical treatment options, with the intent to minimize downtime, scarring, and expenses. For more information, visit: https://avanturol.com/.

 

About CLS

Clinical Laserthermia Systems AB (publ) develops and sells the TRANBERG®|Thermal Therapy Systems, including Thermoguide Workstation and sterile disposables, for minimally invasive treatment of cancer tumors and drug-resistant epilepsy, according to regulatory approvals in the EU and the US. The products are marketed for image-guided laser ablation and used in studies for treatment with imILT®, the Company's interstitial laser thermotherapy for immunostimulant ablation with potential abscopal effects. CLS is headquartered in Lund and has subsidiaries in Germany, the US and Singapore. CLS is listed on the Nasdaq First North Growth Market under the symbol CLS B. The Certified Advisor (CA) is FNCA Sweden AB, Tel: +46 8 528 00 399. E-mail: info@fnca.se.

 

For more information about CLS, please visit the Company's website: clinicallaser.se

 

Subscribe